Legislation Would Require Hospitals To Report Procedure Costs
This article was originally published in The Gray Sheet
A bi-partisan bill introduced in the Senate Oct. 6 would require hospitals across the nation to reveal the prices of their most frequently performed procedures and most frequently administered drugs
You may also be interested in...
Biopharma was an attractive investment in 2020 and fundamentals are unchanged in 2021, including the pandemic’s work-at-home requirements, which allowed more companies to go public faster.
Abbott reported almost 28% revenue growth in the fourth quarter led by the exploding demand for COVID-19 tests and continued success of its FreeStyle Libre continuous glucose monitor.
While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.